JNJ

239.59

+0.19%↑

UNH

272.25

+0.46%↑

TMO

541.64

-2.07%↓

ABT

109.11

-0.05%↓

ISRG

489.27

+1.34%↑

JNJ

239.59

+0.19%↑

UNH

272.25

+0.46%↑

TMO

541.64

-2.07%↓

ABT

109.11

-0.05%↓

ISRG

489.27

+1.34%↑

JNJ

239.59

+0.19%↑

UNH

272.25

+0.46%↑

TMO

541.64

-2.07%↓

ABT

109.11

-0.05%↓

ISRG

489.27

+1.34%↑

JNJ

239.59

+0.19%↑

UNH

272.25

+0.46%↑

TMO

541.64

-2.07%↓

ABT

109.11

-0.05%↓

ISRG

489.27

+1.34%↑

JNJ

239.59

+0.19%↑

UNH

272.25

+0.46%↑

TMO

541.64

-2.07%↓

ABT

109.11

-0.05%↓

ISRG

489.27

+1.34%↑

Начало・Списък с акции・Lisata Therapeutics

L
Lisata Therapeutics

Отворен

4.54 -2.37

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

4.36

Максимум

4.67

Ключови измерители
By Trading Economics
Служители	26

Дивиденти
By Dow Jones
Следващи печалби	26.02.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	15M 35M
Предишно отваряне	6.91
Предишно затваряне	4.54

Lisata Therapeutics Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

5.02.2026 г., 23:57 ч. UTC

Печалби

Naver Has Record Year Despite Weaker Final Quarter

5.02.2026 г., 23:45 ч. UTC

Горещи акции

Stocks to Watch: Amazon, Coty, Gen Digital, Roblox

5.02.2026 г., 22:26 ч. UTC

Печалби

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9% -- Update

5.02.2026 г., 22:00 ч. UTC

Печалби

REA Group Lifts Dividend, Announces Buyback as 1st Half Profit Rises 9%

5.02.2026 г., 23:47 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

5.02.2026 г., 23:47 ч. UTC

Пазарно говорене

Nikkei May Fall After U.S. Tech Stock Drops -- Market Talk

5.02.2026 г., 23:43 ч. UTC

Пазарно говорене

Gold Falls on Spillover Impact From Cryptocurrencies' Selloff -- Market Talk

5.02.2026 г., 23:37 ч. UTC

Пазарно говорене

Glencore Shares Look Cheap After Failed Takeover Talks -- Market Talk

5.02.2026 г., 23:20 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 5th Update

5.02.2026 г., 23:11 ч. UTC

Пазарно говорене

Amazon CEO Confident in Return on $200B Investment -- Market Talk

5.02.2026 г., 23:09 ч. UTC

Печалби

Naver 2025 Net KRW1.820T Vs. Net KRW1.932T >035420.SE

5.02.2026 г., 23:08 ч. UTC

Печалби

Naver 2025 Oper Pft KRW2.208T Vs. Pft KRW1.979T >035420.SE

5.02.2026 г., 23:07 ч. UTC

Печалби

Naver 2025 Rev KRW12.035T Vs. KRW10.738T >035420.SE

5.02.2026 г., 23:03 ч. UTC

Пазарно говорене

Печалби

REA's Update Looks Negative Despite A$200M Buyback -- Market Talk

5.02.2026 г., 23:03 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Bitcoin Booster's $12 Billion Loss Headlines Crypto's Worst Day Since 2022 Crash -- WSJ

5.02.2026 г., 23:00 ч. UTC

Печалби

Naver 4Q Net Profit Missed FactSet-Compiled Consensus

5.02.2026 г., 23:00 ч. UTC

Печалби

Naver 4Q Net KRW164.60B Vs. Net KRW514.00B >035420.SE

5.02.2026 г., 22:59 ч. UTC

Печалби

Naver 4Q Oper Pft KRW610.60B Vs. Pft KRW542.00B >035420.SE

5.02.2026 г., 22:59 ч. UTC

Печалби

Naver 4Q Rev KRW3.195T Vs. KRW2.886T >035420.SE

5.02.2026 г., 22:52 ч. UTC

Печалби

Alphabet Stock Is Taking a Hit After Strong Earnings. Don't Panic. -- Barrons.com

5.02.2026 г., 22:45 ч. UTC

Печалби

Amazon Stock Falls Sharply on Earnings. Spending Continues to Soar. -- Barrons.com

5.02.2026 г., 22:37 ч. UTC

Пазарно говорене

Woolworths's Profit Margin Likely Faces 2Q Squeeze -- Market Talk

5.02.2026 г., 22:11 ч. UTC

Печалби

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9% -- Update

5.02.2026 г., 22:03 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Amazon to Spend $200 Billion as It Accelerates AI Projects -- 4th Update

5.02.2026 г., 22:01 ч. UTC

Печалби

Reddit Stock Jumps on Earnings. CFO Cites Modest AI Spending. -- Barrons.com

5.02.2026 г., 21:59 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

What's Next For Rio Tinto, Glencore After Deal Talks Fail? -- Market Talk

5.02.2026 г., 21:51 ч. UTC

Печалби

Придобивния, сливания и поглъщания

Saylor's Strategy Posts $12 Billion Quarterly Loss on Bitcoin Selloff -- WSJ

5.02.2026 г., 21:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Basic Materials Roundup: Market Talk

5.02.2026 г., 21:49 ч. UTC

Печалби

Why Google's Bad News Was Good News for Broadcom and Nvidia -- Barrons.com

5.02.2026 г., 21:45 ч. UTC

Печалби

REA Group Lifts Dividend, Announces Buyback as 1H Profit Rises 9%

Сравнение с други в отрасъла

Ценова промяна

Lisata Therapeutics Прогноза

Консенсусна оценка

By TipRanks

Неутрален

1 ratings

Купи

Задържане

Продай

Според 1 анализатори, дали борсови рейтинги на Lisata Therapeutics през последните 3 месеца.

Финанси

Относно Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.